Drawing for PRESTWICK CHEMICAL

USPTO serial 79209931

PRESTWICK CHEMICAL

Reviewed by CopyMark Law Group

Reg. 5461302Status 709
Filing date
Status date
Registration date
May 8, 2018
Examiner
PEREZ, STEVEN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PRESTWICK CHEMICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical, biological and biotechnical products, compounds and preparations for scientific use, namely, reagents for use in scientific apparatus for chemical or biological analysis; chemical, biochemical, biological and biotechnological products and preparations for scientific use for identification of primary compounds with biological activity, namely, reagents for use in scientific apparatus for chemical or biological analysis; chemical, biochemical, biological, biotechnological products for laboratory analysis other than for medical or veterinary use, namely, reagents for use in scientific apparatus for chemical or biological analysis; diagnostic preparations other than for medical or veterinary use; chemical reagents other than for medical or veterinary useSECTION 71 - CANCELLED—
005Chemical, biochemical, biological and biotechnological products, compounds and preparations for medical, pharmaceutical or veterinary use, namely, vaccines or chemical preparations for the diagnosis of pregnancy; chemical, biochemical, biological and biotechnological products, compounds and preparations for medical, pharmaceutical or veterinary use in the nature of reagents for medical use for identification of primary compounds with biological activity; chemico-pharmaceutical products, namely, vaccines; bacterial and bacteriological preparations for medical or veterinary use; diagnostic preparations for medical or veterinary use, chemical reagents for medical or veterinary use; cultures and preparations of microorganisms for medical or veterinary useSECTION 71 - CANCELLED—
042Scientific and industrial research in the field of pharmaceuticals; scientific research in pharmacology and pharmacochemistry; scientific research and technical development of biochemical analysis and biological analysis techniques; scientific analysis, consultancy and information services relating to biology and biotechnology; research and development of new products in the field of pharmacy, biology and biotechnology, medicine and science; research laboratories, namely, scientific and medical research laboratory services; scientific research services provided by engineers in the field of pharmacology, medicine and scienceSECTION 71 - CANCELLED—
044Health care services, namely, medical analysis services relating to pharmaceutical treatment; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicines; medical and pharmaceutical consultationSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 26, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 29, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jan 15, 2026INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jan 15, 2026INPCINVALIDATION PROCESSED—
Jul 22, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 3, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 22, 2024C71TCANCELLED SECTION 71—
May 8, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 8, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 1, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 1, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 9, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 30, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
Sep 7, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 16, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 16, 2018FIMPFINAL DISPOSITION PROCESSED—
Aug 8, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 8, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 20, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 20, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 31, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 14, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 12, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 12, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 12, 2018ALIEASSIGNED TO LIE—
Dec 28, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 21, 2017RFNTREFUSAL PROCESSED BY IB—
Jul 1, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 1, 2017RFRRREFUSAL PROCESSED BY MPU—
Jun 25, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 24, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 20, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 16, 2017DOCKASSIGNED TO EXAMINER—
Jun 16, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 15, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance